Evidence map›Paper›PMID 28204825›Full record

ArticleInternational journal of molecular medicine2017

Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage.

Jing-Xing Zhang, Rui Wang, Jin Xi, Lin Shen, An-You Zhu, Qi Qi, Qi-Yi Wang, Lun-Jun Zhang, Feng-Chao Wang, He-Zuo Lü and 1 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in International journal of molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Neurotrophic Natural Products.Progress in the chemistry of organic natural products · 2024
    Article
  11. Review
  12. Function of GSK‑3 signaling in spinal cord injury (Review).Experimental and therapeutic medicine · 2023
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Morroniside Protects Human Granulosa Cells against HEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  18. Article
  19. Article
  20. Morroniside protects OLN-93 cells against HCell cycle (Georgetown, Tex.) · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jing-Xing ZhangDepartment of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
Rui WangAnhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
Jin XiAnhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
Lin ShenAnhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
An-You ZhuDepartment of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
Qi QiAnhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
Qi-Yi WangAnhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
Lun-Jun ZhangDepartment of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
Feng-Chao WangDepartment of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
He-Zuo LüDepartment of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
Jian-Guo HuDepartment of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China.
First Affiliated Hospital of Bengbu Medical College · CNBengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress-induced cell injury has been linked to the pathogenesis of neurodegenerative disorders such as spinal cord injury, Parkinson's disease, and multiple sclerosis. Morroniside is an antioxidant derived from the Chinese herb Shan-Zhu-Yu. The present study investigated the neuroprotective effect of morroniside against hydrogen peroxide (H2O2)-induced cell death in SK-N-SH human neuroblastoma cells. H2O2 increased cell apoptosis, as determined by flow cytometry and Hoechst 33342 staining. This effect was reversed by pretreatment with morroniside at concentrations of 1-100 µM. The increase in intracellular reactive oxygen species (ROS) generation and lipid peroxidation induced by H2O2 was also abrogated by morroniside. H2O2 induced a reduction in mitochondrial membrane potential, increased caspase-3 activity, and caused downregulation of B cell lymphoma-2 (Bcl-2) and upregulation of Bcl-2-associated X protein (Bax) expression. These effects were blocked by morroniside pretreatment. Thus, morroniside protects human neuroblastoma cells against oxidative damage by inhibiting ROS production while suppressing Bax and stimulating Bcl-2 expression, thereby blocking mitochondrial-mediated apoptosis. These results indicate that morroniside has therapeutic potential for the prevention and treatment of neurodegenerative diseases.

Indexed as

ApoptosisApoptosis Regulatory ProteinsCaspase 3Cell Line, TumorCell SurvivalGlycosidesHumansHydrogen PeroxideLipid PeroxidationMatrix MetalloproteinasesMembrane Potential, MitochondrialNeuroblastomaNeuroprotective AgentsOxidantsOxidative StressReactive Oxygen SpeciesApoptosis Regulatory ProteinsCaspase 3GlycosidesHydrogen PeroxideMatrix MetalloproteinasesmorronisideNeuroprotective AgentsOxidantsReactive Oxygen SpeciesSuperoxide Dismutase

Identifiers

PMID28204825
PMCPMC5360361
OpenAlexW2587544307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.